Searched for
MALARIA CURE
10,000-year-old disease that haunted Greeks and Chinese, weakened Civil War soldiers and caused 5% of 20th century deaths may finally have a weakness; Indian researchers find breakthroughScientists from India and Britain have identified a protein called Ark1 that acts as a control switch in the malaria parasite's cell divisi...- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOil is crucial for every part of the Indian economy: From government to consumer, its price impacts spending by every stakeholder. So, till...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Zydus Cadila receives orphan drug status from USFDA for its novel malaria drugDrug maker Cadila Healthcare (Zydus Cadila), on Thursday said its antimalarial drug ZY19489 (MMV253), currently in development together wit...
- Miraculous medicines are always more myth than reality: Pandemics, prophylactics and pice packetsOseltamivir was that drug during bird flu several years back, and hydroxychloroquine (HCQ) is the drug today. President Trump’s demands for...
- Hydroxychloroquine consignment from India arrives in USEarlier this week, India at the request of President Donald Trump cleared the export of 35.82 lakh tablets of hydroxychloroquine to the US ...
- IIT researchers develop promising TB diagnostics solutionA team from IIT-Delhi is working on homegrown solutions for easier & cheaper diagnosis of TB and malaria.
- Did you know Bengaluru was the centre of Nobel Prize-winner Ronald Ross's work on malarial parasite?Ross’s study of parasite in Bengaluru won him 1902 Nobel Prize for medicine.
- Serious malaria cases cured by plant therapy in AfricaBengaluru, April 27 (IANS) In a stunningly successful trial, scientists report they cured 18 critically-ill patients suffering from drug-re...
- Zydus partners Swiss non-profit for malaria drug developmentUnder its latest tie-up, Zydus will lead the development of the compound, called MMV674253, while MMV will provide scientific expertise.
- Cancer cases to rise by 75 per cent in 20 yearsCancer cases worldwide are forecast to rise by 75 per cent and reach close to 25 million in the next two decades.
- Indian scientist helps find breakthrough malaria cureDr Mahmood Alam, from Lohardaga in Jharkhand, is among the authors of the new study published in the journal 'Nature Communications' .
- Experts warn of malaria's adverse impact on reproductive healthExperts said on the occasion of World Malaria Day as they pointed out that, although rare, the disease can hamper semen quality in males an...
- Ranbaxy gets approval to launch Synriam in 7 African countriesThe product has already been launched in Uganda and will be made available in other six countries towards the end of January 2015, it added.
- New finding could lead to better malaria treatmentThe team are working to design molecules that target NMT more potently, and hope to start clinical trials of potential treatments.
- Malaria research requires USD 8.3 billion: ReportThe study warns that R&D investments are critical, given the emergence of drug resistance in the malaria parasite and insecticide resistanc...
- New drug target to fight malaria identifiedThe disease is caused by Plasmodium parasites, which are transmitted to humans by the infectious bite of an Anopheles mosquito.
- Drug to offer 'single-dose' malaria cure foundScientists claim to have discovered a drug that could cure all strains of malaria with a single oral dose and also block transmission of th...
- Novartis cuts cost of malaria drug Coartem by 20%Swiss drug maker Novartis says it is lowering the public-sector price of its antimalarial drug Coartem by 20 per cent.
Load More
